Preliminary research demonstrate that this peptide – a dual agonist of gut hormone and GIP receptors – presents a considerable improvement in weight loss therapies. In contrast to existing therapies, the peptide seems to influence hunger and energy utilization through multiple mechanisms . While additional examination is required , early result